These MJD84.2 transgenic mice harbor a YAC transgene that expresses a human (ATXN3 gene modified with an expanded 84 CAG repeat motif that is associated with Machado-Joseph disease in humans.
Ilya Bezprozvanny, UT Southwestern Medical Center at Dallas
Genetic Background | Generation |
---|---|
?+pN1
|
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
Starting at:
$255.00 Domestic price for female 4-week |
333.51 Domestic price for breeder pair |
$2,854.50 Domestic price Cryo Recovery |
MJD84.2 transgenic mice (also called SCA3-YAC-84Q) harbor a YAC transgene that expresses a human ataxin 3 gene (ATXN3; also called Machado-Joseph disease [MJD], MJD1, or spinocerebellar ataxia 3 [SCA3]) modified with a human MJD/SCA3-associated 84 CAG repeat expansion [(CAG)2CAAAAGCAGCAA(CAG)78 repeat motif (Q3KQ80), also referred to as (CAG)84]. See below for comment on CAG repeat stability. These MJD84.2 transgenic mice may be useful in studying the progressive neurodegenerative processes underlying Machado-Joseph disease/spinocerebellar ataxia 3 (MJD/SCA3) pathogenesis and other polyglutamine and trinucleotide repeat disorders.
Hemizygous mice (MJD84.2) harbor two copies of the transgene at a single genomic integration site, with transgene expression levels and patterns almost identical to endogenous MJD. Transgene expression is widespread - detected in the cerebellum, cerebral cortex, heart, lung, spleen, liver and skeletal muscle. Stable transmission of the MJD1/CAG84 transgene has been demonstrated for multiple generations with a predicted frequency of about 50%.
Hemizygous mice are viable and fertile, exhibiting attenuated weight gain and a progressive neurological phenotype. The neurological phenotype is characterized by prominent gait abnormalities (~4 weeks), mild tremor, moderate hypoactivity, forelimb/hindlimb clasping (~24 weeks), inability to correct during negative geotaxis (~20 weeks), marked neuronal degeneration and mild gliosis of the dentate and pontine nerve nuclei, atrophy of the cerebellar Purkinje and molecular cell layers, and increased neuronal intranuclear inclusions (NIIs) that are ubiquitinated. With age, mice develop deficits in beam walking and gait walking assays, as well as neuronal loss in pontine nuclei and substantia nigra regions.
Homozygous mice (MJD84.2/84.2) exhibit increased severity and earlier onset of symptoms, as well as excessive grooming.
For these MJD84.2 mice, the donating investigator did not sequence the CAG repeat expansion over time. It is unknown if the CAG repeat number is subject to germline and somatic instability (whether it may expand or contract). When using lines with CAG repeat length, it is strongly recommended the CAG repeat number be quantified in all the experimental animals; all animals in all experimental groups should carry comparable CAG repeat sizes. CAG repeat sizing in mice should be done using high-resolution methods; as assays based on agarose gel electrophoresis may not provide sufficient resolution to accurately measure CAG repeat numbers. If labs do not have access to the appropriate equipment for determining CAG repeat length, CAG repeats can be evaluated on a fee-for-service basis by Laragen, Inc.
It is the experience of The Jackson Laboratory that the CAG repeat values of hemizygous MJD84.2 mice (a single genomic integration of two copies of the transgene) have been generally consistent over time, with the Laragen assay reporting ~65-78 CAG repeats [June 2020].
The MJD84.2 transgenic mice (also called SCA3-YAC-84Q transgenic mice) were generated in the laboratory of Drs. Cemal K. Cemal, Mark A. Pook, and Susan Chamberlain (Imperial College, London, United Kingdom). The 250 kb human yeast artificial chromosome (YAC) 9AF12, containing the entire ~48 kb human ataxin 3 genomic locus (ATXN3; also called Machado-Joseph disease (MJD), MJD1, or spinocerebellar ataxia 3 (SCA3)) and ~35 kb of 5' and ~170 kb of 3' flanking sequences, was modified by introducing expanded CAG repeat motifs into the exon 4 region of the ATXN3 locus. The URA3 gene on the YAC was ablated in this process. A modified YAC construct with the (CAG)2CAAAAGCAGCAA(CAG)78 repeat motif (Q3KQ80), also referred to as (CAG)84, was identified and used as a source of the MJD1/CAG84 transgene. The MJD1/CAG84 transgene was microinjected into the pronuclei of (C57BL/6J x CBA/Ca)F2 oocytes, and transgenic founders were bred with C57BL/6J mice. Mice from founder line MJD84.2 were found to have a single genomic integration of two copies of the transgene. MJD84.2 transgenic mice on a "C57BL/6J" genetic background were used to cryopreserve sperm, and this sperm was sent to the laboratory of Drs. Ilya Bezprozvanny and Robert E. Hammer (University of Texas Southwestern Medical Center at Dallas). There, sperm was used to fertilize C57BL/6 oocytes to generate their colony. The resulting MJD84.2 transgenic mice on a C57BL/6 genetic background (B6.SCA3-YAC-84Q mice) were bred with wildtype mice from the colony for several generations (see SNP note below), and then sent to The Jackson Laboratory Repository. Upon arrival at The Jackson Laboratory Repository, mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. At least 13 markers on 11 chromosomes were found to be segregating, suggesting an incomplete backcross.
Expressed Gene | ATXN3, ataxin 3, human |
---|---|
Site of Expression |
Allele Name | transgene insertion 84.2, Cemal K Cemal |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | MJD84.2; Q84; SCA3-YAC-84Q; YAC84Q |
Gene Symbol and Name | Tg(ATXN3*)84.2Cce, transgene insertion 84.2, Cemal K Cemal |
Gene Synonym(s) | |
Promoter | ATXN3, ataxin 3, human |
Expressed Gene | ATXN3, ataxin 3, human |
Strain of Origin | (C57BL/6J x CBA/Ca)F2 |
Chromosome | UN |
Molecular Note | A 250 kb YAC containing the intact human locus with 15 CAG trinucleotide repeats in exon 10 was modified by homologous recombination to expand the number of CAG repeats to 84. Two copies of the transgene inserted into this line with the number of CAG repeats for both copies confirmed by sequencing (a second founder line, 84.1, had insertion of 2 transgenes with variant triplets and altered repeat numbers). Transgene expression was detected in the cerebellum at endogenous levels and was also detected in the cerebral cortex, heart, and skeletal muscle. |
Mutations Made By | Cemal Cemal, Imperial College |
When maintaining a live colony, hemizygous mice may be bred to wildtype (noncarrier) mice from the colony or with C57BL/6J inbred mice (Stock No. 000664). Hemizygous mice exhibit a progressive neurological phenotype. Homozygous mice exhibit increased severity and earlier onset of neurological symptoms.
When using the B6;CBA-Tg(ATXN3*)84.2Cce/IbezJ mouse strain in a publication, please cite the originating article(s) and include JAX stock #012705 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Hemizygous or non-carrier for Tg(ATXN3*)84.2Cce |
Frozen Mouse Embryo | B6;CBA-Tg(ATXN3*)84.2Cce/IbezJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;CBA-Tg(ATXN3*)84.2Cce/IbezJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;CBA-Tg(ATXN3*)84.2Cce/IbezJ Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6;CBA-Tg(ATXN3*)84.2Cce/IbezJ Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.